Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.
about
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study.Novel approaches to the management of noneosinophilic asthma.Human Lung Mast Cell Products Regulate Airway Smooth Muscle CXCL10 Levels.Rosiglitazone elicits in vitro relaxation in airways and precision cut lung slices from a mouse model of chronic allergic airways disease.
P2860
Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Thiazolidinediones inhibit air ...... with current asthma therapies.
@en
type
label
Thiazolidinediones inhibit air ...... with current asthma therapies.
@en
prefLabel
Thiazolidinediones inhibit air ...... with current asthma therapies.
@en
P2093
P2860
P356
P1433
P1476
Thiazolidinediones inhibit air ...... with current asthma therapies.
@en
P2093
Daniel J Lalor
Hatem Alkhouri
J Margaret Hughes
Janette K Burgess
Petra Seidel
P2860
P2888
P356
10.1186/1465-9921-13-90
P577
2012-10-04T00:00:00Z
P5875
P6179
1042121545